Pressemitteilungen von Aji Bio-Pharma Pressemitteilungen December 18, 2018 Ajinomoto and XL-protein forge Strategic Alliance to develop PASylated therapeutics applying the CORYNEX® platform Weiterlesen November 28, 2018 Ajinomoto Bio-Pharma Services Introduces AJICAP Bioconjugation Technology for ADC Manufacturing Weiterlesen October 23, 2018 Precision NanoSystems Announces Manufacturing Collaboration Agreement with Ajinomoto Bio-Pharma Services for GMP Manufacturing of High Quality Nanomedicines Weiterlesen October 2, 2018 Ajinomoto Althea and OmniChem Combine to Form Ajinomoto Bio-Pharma Services, Reflecting a Collective Range of Services Offered to the Bio-Pharma Industry Weiterlesen April 14, 2017 Ajinomoto OmniChem Launches Flow Chemistry for API Commercial Manufacturing Weiterlesen April 13, 2017 Ajinomoto OmniChem Launches Flow Chemistry for API Commercial Manufacturing Weiterlesen December 18, 2016 Ajinomoto Group Acquires All Shares of GeneDesign, a Nucleic Acid Drug CDMO, to Accelerate Expansion of the Contract Business for Oligonucleotides. Weiterlesen
